Don't miss out on this cutting-edge biotech company! This Little-Known Biotech Just Had a Gene Therapy Breakthrough... This biotech "hidden gem" company recently announced promising data from a Q1 2023 study evaluating a gene therapy for Type 1 diabetes that resulted in reduced insulin requirements and improved glucose tolerance, supporting the potential for advanced human clinical trials. Interested? Find out the company name and ticker symbol. |